Forschung & Information
Wissenschaftliche Laufbahn
- 2012 Habilitation und Erlangung der Venia Docendi für das Fach Dermatologie und Venerologie
- 2009 Wissenschaftliche Mitarbeiterin und Lehrtätigkeit an der Univ. Klinik für Dermatologie und Venerologie, Medizinische Universität Graz
- 2009 Lehre an der Donau-Universität Krems
- 2004 -2009 Ausbildung zur Fachärztin an der Univ. Klinik für Dermatologie und Venerologie Graz, Medizinische Universität Graz. Facharztprüfung: 06.06.2008
- 2004 -2006 Postgraduales Studium der Telemedizin, FH Joanneum Graz. Sponsion zum Master of Science of Telemedicine am 30.06.2006
- 2002 -2009 Turnus/Gegenfächer: Universitätsklinik an der TU Dresden, Unfallkrankenhaus Salzburg, Medizinische Universität Graz
- 2002 -2002 Wissenschaftliche Mitarbeiterin an der Abteilung für Dermatologie und Venerologie, Wilhelminenspital, Wien
- 2001 -2002 Wissenschaftliche Mitarbeiterin an der Abteilung für Pädiatrie, Universitätsklinik Wien (Chromosomenlabor)
- 2001 -2002 Wissenschaftliche Mitarbeiterin der Wiener Schlaganfalldatenbank und Mitglied der Vienna stroke study group, Abteilung für Neurologie, Universitätsklinik Wien
- 1995 -2001 Studium der Humanmedizin. Promotion zum Doktor der gesamten Heilkunde am 21.03.200
Auszeichnungen
- 2011 Hans-Weitgasser-Preis (Erstautor), Wissenschaftliche Vereinigung der Steirischen Dermatologen
- 2009 Kyrle Reisestipendium der Österreichischen Gesellschaft für Dermatologie und Venerologie
Publikationen
Soft tissue cervicofacial emphysema after dental treatment: report of 2 cases with emphasis on the differential diagnosis of angioedema.
BACKGROUND: The development of soft tissue cervicofacial emphysema after dental treatment is a rare complication, with few descriptions in the dermatologic literature. It is usually restricted to only moderate local swelling. However, spread of larger [...]
Serum level of VEGF-D in patients with primary lymphedema.
Recent studies have indicated that vascular endothelial growth factor-D (VEGF-D) stimulates lymphangiogenesis in humans. Furthermore, mutations of vascular endothelial growth factor receptor 3 (VEGFR-3) have been observed in families with hereditary lymphedema. The lack of [...]
Determination of lipid profiles and use of statins in patients with ischemic stroke or transient ischemic attack.
BACKGROUND AND PURPOSE: Statins reduce the risk of myocardial infarction and stroke in patients with vascular disease. Inappropriate serum lipid determination and underuse of statins have been documented in patients with coronary artery disease. Evaluation [...]
Proteomic evaluation of intermediary metabolism enzyme proteins in fetal Down’s syndrome cerebral cortex.
Trisomy 21 (Down's syndrome) is the most common genetic cause of human mental retardation. In Down's syndrome (DS) patients, deteriorated glucose, lipid, purine, folate and methionine/homocysteine metabolism has been reported. In our study, we used [...]
Current strategies of secondary prevention after a cerebrovascular event: the Vienna stroke registry.
BACKGROUND AND PURPOSE: Oral anticoagulation (OAC) and antiplatelet drugs are effective in the secondary prevention of ischemic cerebrovascular events. Only few data exist about the factors influencing the choice of a specific therapy for secondary [...]
Präsentationen
Varizella-zoster- (VZV) und Herpes-simplex- (HSV) Virusinfektionen in der Schwangerschaft: Klinik, Therapie und fetale Prognose.
-2008; -52. Jahrestagung der Österreichischen Gesellschaft für Dermatologie und Venerologie; NOV, 28-30, 2008; Vienna, AUSTRIA. [Poster]
Varicella-zoster virus (VZV) infection in pregnancy: Epidemiology, clinical presentation, and fetal outcome.
Abstract CD-ROM. 2008; -17th Congress of the European Academy of Dermatology and Venereology; SEPT 17-21, 2008; Paris, FRANCE. [Poster]
Patient and physician acceptance of MPS, a mobile patient support-system for the home monitoring of high-need psoriasis patients.
Abstract CD-ROM. 2008; -17th congress of European Academy of Dermatology and Venerology; SEPT 17-21, 2008; Paris, FRANCE. [Oral Communication]
MPS: mobiler Patienten Support zur Verlaufskontrolle bei therapieresistenter Psoriasis.
Fortbildungsseminar der Univ.-Klinik für Dermatologie und Venerologie, Graz; JAN 22, 2008; Graz, AUSTRIA. 2008. [Oral Communication]
Patients‘ compliance during specific allergen immunotherapy – frequency of dropouts and underlying reasons
Allergy. 2008; 63: 146-146. Congress of the European Academy of Allergology and Clinical Immunology; June 7-11, 2008; Barcelona, Spain. [Poster]
CXCL13: a valuable biomarker for monitoring lupus flares?
J Invest Dermatol 2008; 128:S181-S181. International Investigative Dermatology Meeting 2008; May 14-17, 2008; Kyoto, Japan [Poster]